Tag: (NASDAQ:TORC)

July 23, 2019

resTORbio Completes Early Enrollment of Phase 3 PROTECTOR 1 Trial with RTB101

resTORbio (NASDAQ:TORC) has announced it has finished enrolling patients in the Phase 3 PROTECTOR 1 trial ahead of schedule. As...
June 9, 2019

5 Top Weekly NASDAQ Biotech and Pharma Stocks: La Jolla Soars

INN looks at the top NASDAQ biotech and pharma stocks over the course of the week and what may have...
March 22, 2019

resTORbio Announces Closing Public Offering of Common Stock

resTORbio (NASDAQ:TORC) has announced the closing of a previously announced underwritten public offering of 7.2 million shares of its common...
October 17, 2018

resTORbio Releases Additional Trial Data

Months after releasing initial positive topline data for its Phase 2b trial of RTB101, resTORbio provided additional data on Tuesday...
October 16, 2018

resTORbio Announces Additional RTB101 Phase 2b Data

resTORbio (Nasdaq:TORC) today announced additional positive results from its dose-ranging Phase 2b clinical trial of RTB101, an oral, selective and potent...